Table 1 Functional observational battery assessing the effects of a subcutaneous PMP1 injection in WT and AS mice.

From: A prodrug targeting CIM6P/IGF2R enhances memory in healthy mice and reverses deficits in an Angelman syndrome mouse model

Pre-treatment/30 min post-treatment

 

WT Veh (n = 8)

WT PMP1 (n = 9)

AS Veh (n = 8)

AS PMP1 (n = 7)

 

Pre

Post

Pre

Post

Pre

Post

Pre

Post

Physical Characteristics

Weight (males)

25.6±0.6

25.0±0.7

23.1±3.0

23.4±2.5

26.0±3.4

26.0±3.2

28.5±0.7

28.5±0.7

Weight (females)

19.3±1.2

18.3±0.6

20.5±3.5

17.5±0.7

17.3±2.1

18.3±0.6

22.2±3.3

22.8±1.3

Temp

35.3±0.3

35.2±0.3

35.0±0.1

35.5±0.6

35.5±0.2

35.3±0.3

35.3±0.3

35.3±0.2

Whiskers

100

100

100

100

100

100

100

100

Bald patch

0

0

0

0

0

0

0

0

Palpebral closure?

12.5

0

0

0

0

0

0

0

Exothalmos

0

0

0

0

0

0

0

0

General Behavior - Recorded 1 min in novel empty cage

Sniffing

100

100

100

100

100

100

100

100

Licking

0

0

0

11.1

0

0

0

0

Rearing

100

100

100

100

87.5

100

100

100

Wild run

25

0

11.1

11.1

25

25

14.3

0

Freezing

0

0

0

0

0

0

0

0

Jumping

0

0

0

0

0

0

0

0

Defecation

25

37.5

33.3

44.4

25

12.5

42.9

14.3

Urination

100

100

100

100

100

100

100

100

Sensorimotor Reflexes (% of subjects showing normal response)

Righting

100

100

100

100

100

100

100

100

Whiskers

100

100

100

100

100

100

100

100

Eye-blink

100

100

100

100

100

100

100

100

Ear-twitch

100

100

100

100

100

100

100

100